XTX Topco Ltd Acquires Shares of 17,157 Masimo Co. (NASDAQ:MASI)

XTX Topco Ltd bought a new stake in Masimo Co. (NASDAQ:MASI - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 17,157 shares of the medical equipment provider's stock, valued at approximately $2,288,000.

Several other hedge funds have also modified their holdings of the stock. NBC Securities Inc. boosted its holdings in Masimo by 47.1% in the third quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 73 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Masimo by 75.0% during the second quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider's stock worth $33,000 after buying an additional 111 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its position in shares of Masimo by 133.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider's stock worth $44,000 after buying an additional 200 shares in the last quarter. HHM Wealth Advisors LLC increased its stake in shares of Masimo by 25.0% in the second quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider's stock worth $79,000 after buying an additional 125 shares during the last quarter. Finally, Fifth Third Bancorp raised its holdings in Masimo by 16.4% in the second quarter. Fifth Third Bancorp now owns 695 shares of the medical equipment provider's stock valued at $88,000 after acquiring an additional 98 shares in the last quarter. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Trading Up 0.2 %

Shares of NASDAQ MASI traded up $0.40 during mid-day trading on Friday, hitting $169.79. 253,379 shares of the company traded hands, compared to its average volume of 513,913. The business has a 50 day moving average of $153.35 and a two-hundred day moving average of $131.56. The stock has a market capitalization of $9.09 billion, a price-to-earnings ratio of 117.10 and a beta of 1.01. Masimo Co. has a 1 year low of $101.35 and a 1 year high of $178.27. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50.

Masimo (NASDAQ:MASI - Get Free Report) last announced its earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, topping the consensus estimate of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The company had revenue of $504.60 million during the quarter, compared to analysts' expectations of $502.87 million. During the same period last year, the company posted $0.63 earnings per share. The business's revenue for the quarter was up 5.4% on a year-over-year basis. On average, sell-side analysts anticipate that Masimo Co. will post 4.03 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have weighed in on MASI. Raymond James raised shares of Masimo from a "market perform" rating to an "outperform" rating and set a $170.00 price objective for the company in a report on Wednesday, November 6th. BTIG Research upped their price objective on Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a research note on Monday, October 14th. Wells Fargo & Company lifted their target price on Masimo from $160.00 to $171.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. Piper Sandler upped their price target on Masimo from $165.00 to $180.00 and gave the company an "overweight" rating in a research report on Wednesday, November 6th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Masimo in a report on Wednesday, November 6th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $167.00.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.